Literature DB >> 815171

Evidence for a serum inhibitor of Clq.

J D Conradie, J E Volanakis, R M Stroud.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 815171     DOI: 10.1016/0019-2791(75)90260-8

Source DB:  PubMed          Journal:  Immunochemistry        ISSN: 0019-2791


× No keyword cloud information.
  9 in total

1.  A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen.

Authors:  D K Galanakis; B Ghebrehiwet
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

2.  Inhibition of immune complex-mediated activation of complement. Effects of agents modulating activation of, and the activated C1 complex.

Authors:  D S Fletcher; T Y Lin
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

3.  Three step purification of C1q by DNA precipitation, ion exchange and lectin affinity chromatography.

Authors:  M Rhen; E Linder
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

4.  C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.

Authors:  R B Sim; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1979-06-01       Impact factor: 3.857

5.  Purification of the subunit Clq from the first component of equine complement.

Authors:  T L McDonald; D Burger
Journal:  Immunology       Date:  1979-07       Impact factor: 7.397

6.  Studies on circulating immune complexes of the liver disease. 3. Conditions for Clq binding assay and low molecular weight Clq reactants.

Authors:  T Arima; J Narumoto; H Shimomura; K Suwaki; K Kunishi; T Yasuhara; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1980

7.  Purification and characterization of subcomponent C1q of the first component of mouse complement.

Authors:  K Yonemasu; T Sasaki
Journal:  Biochem J       Date:  1981-02-01       Impact factor: 3.857

8.  Complete functional C1q deficiency associated with systemic lupus erythematosus (SLE).

Authors:  M Kirschfink; F Petry; K Khirwadkar; R Wigand; J P Kaltwasser; M Loos
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

9.  Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q.

Authors:  B Ghebrehiwet; B L Lim; E I Peerschke; A C Willis; K B Reid
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.